TW200621708A - Remedy or preventive for ischemic cardiac disease or ischemic cardiomyopathy - Google Patents
Remedy or preventive for ischemic cardiac disease or ischemic cardiomyopathyInfo
- Publication number
- TW200621708A TW200621708A TW094139125A TW94139125A TW200621708A TW 200621708 A TW200621708 A TW 200621708A TW 094139125 A TW094139125 A TW 094139125A TW 94139125 A TW94139125 A TW 94139125A TW 200621708 A TW200621708 A TW 200621708A
- Authority
- TW
- Taiwan
- Prior art keywords
- ischemic
- remedy
- preventive
- cardiac disease
- cardiomyopathy
- Prior art date
Links
- 208000020446 Cardiac disease Diseases 0.000 title abstract 3
- 206010048858 Ischaemic cardiomyopathy Diseases 0.000 title abstract 3
- 208000019622 heart disease Diseases 0.000 title abstract 3
- 230000000302 ischemic effect Effects 0.000 title abstract 3
- 230000003449 preventive effect Effects 0.000 title abstract 3
- 108010006696 Neuronal Apoptosis-Inhibitory Protein Proteins 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 230000008717 functional decline Effects 0.000 abstract 1
- 210000005003 heart tissue Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004326234 | 2004-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200621708A true TW200621708A (en) | 2006-07-01 |
Family
ID=36336438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094139125A TW200621708A (en) | 2004-11-10 | 2005-11-08 | Remedy or preventive for ischemic cardiac disease or ischemic cardiomyopathy |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1815866A1 (zh) |
| JP (1) | JPWO2006051757A1 (zh) |
| CA (1) | CA2591474A1 (zh) |
| TW (1) | TW200621708A (zh) |
| WO (1) | WO2006051757A1 (zh) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9601108D0 (en) * | 1996-01-19 | 1996-03-20 | Univ Ottawa | Neuronal apoptosis inhibitor protein (NAIP) |
| JP2000501416A (ja) * | 1996-04-26 | 2000-02-08 | ユニバーシティー オブ オタワ | ニューロン病を治療し予防するための、治療法および薬物のスクリーニング法 |
| JP2004123562A (ja) * | 2002-09-30 | 2004-04-22 | Japan Science & Technology Corp | 神経細胞死抑制作用を有する化合物を用いた医薬 |
-
2005
- 2005-11-07 EP EP05800236A patent/EP1815866A1/en not_active Withdrawn
- 2005-11-07 WO PCT/JP2005/020381 patent/WO2006051757A1/ja not_active Ceased
- 2005-11-07 JP JP2006544880A patent/JPWO2006051757A1/ja active Pending
- 2005-11-07 CA CA002591474A patent/CA2591474A1/en not_active Abandoned
- 2005-11-08 TW TW094139125A patent/TW200621708A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006051757A1 (ja) | 2006-05-18 |
| EP1815866A1 (en) | 2007-08-08 |
| JPWO2006051757A1 (ja) | 2008-05-29 |
| CA2591474A1 (en) | 2006-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4491622A3 (en) | Cardiac sarcomere inhibitors | |
| RU2498988C2 (ru) | Ингибиторы активности протеинтирозинкиназы | |
| NO20072153L (no) | (Bifenyl)-karboksylsyrer og derivater derav | |
| EA200700058A1 (ru) | Соединения, композиции и способы их использования | |
| EA202190302A1 (ru) | Соединения 2,6-диаминопиридина | |
| WO2011028947A3 (en) | Heterocyclic compounds for the inhibition of pask | |
| EA201791656A1 (ru) | Соединения 4-метилсульфонилзамещенной пиперидинмочевины для лечения дилатационной кардиомиопатии (dcm) | |
| WO2014194245A3 (en) | Cdk8 inhibitors and uses thereof | |
| NO20075386L (no) | Nytt antiarytmisk- og hjertefeilmedikament som retter seg mot lekkasje i ryanodinreseptoren (RYR2) | |
| EP2826472A3 (en) | Telomerase activating compounds and their use | |
| CR20210600A (es) | Compuestos de pirazol disustituidos como inhibidores de cetohexoquinasa | |
| WO2018007525A3 (en) | EPIGENOUS-ASSOCIATION STUDY IDENTIFIES CARDIAC DEVELOPMENT GENE MODELING AND A NEW CLASS OF BIOMARKERS FOR HEART FAILURE | |
| AR068438A1 (es) | Derivado de 6-pirimidinil-pirimid-2-ona | |
| BR112022000523A2 (pt) | Polimorfo, métodos para preparar polimorfo, para tratar doença cardíaca, para tratar uma doença ou condição e para inibir o sarcômero cardíaco, e, composição farmacêutica | |
| NO20070148L (no) | Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen | |
| AR030643A1 (es) | Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular | |
| WO2014194242A3 (en) | Flt3 inhibitors and uses thereof | |
| RU2008119994A (ru) | Ингибиторы калиевых каналов | |
| EA200600740A1 (ru) | Соединения и способы для лечения и предотвращения сердечных аритмий, вызванных физической нагрузкой | |
| TW200621708A (en) | Remedy or preventive for ischemic cardiac disease or ischemic cardiomyopathy | |
| WO2003106445A1 (en) | Compounds and methods for controlling bacterial virulence | |
| WO2007005620A3 (en) | Arginase ii: a target treatment of aging heart and heart failure | |
| ATE448785T1 (de) | Behandlung von entzündlicher darmerkrankung | |
| NO20080860L (no) | Substituert propanamidderivat og farmasoytisk preparat som inneholder dette | |
| MX2009012644A (es) | Derivados de di(hetero)arilciclohexano, su preparacion, su uso y composiciones farmaceuticas que los comprenden. |